---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-017948"
form_type: "8-K"
ticker: "MAIA"
cik: "0001878313"
company_name: "MAIA Biotechnology, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:58:54.865821+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MAIA Biotechnology announces $736,600 private placement of common stock and warrants

## Summary
- Private placement of 603,769 shares at $1.22 per share with warrants to purchase 603,769 shares at $1.52.
- Gross proceeds ~$736,600; warrants exercisable after six months, three-year term.
- Proceeds to fund Step 1 of Part C of Phase II trial THIO-101 for NSCLC and for working capital.
- Closing expected October 15, 2025; securities issued as restricted, no registration rights.
- Offering exempt under Section 4(a)(2)/Reg D; shares and underlying not registered.

## SEC filing metadata
- accession: 0001493152-25-017948
- form_type: 8-K
- ticker: MAIA
- cik: 0001878313
- company_name: MAIA Biotechnology, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1878313/000149315225017948/0001493152-25-017948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1878313/000149315225017948/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-017948
- JSON: https://secwatch.observer/filing/0001493152-25-017948.json
- Plain text: https://secwatch.observer/filing/0001493152-25-017948.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.